Italia markets closed

FTSE MIB
34.249,77
+310,02(+0,91%)
Dow Jones
38.239,66
+153,86(+0,40%)
Nasdaq
15.927,90
+316,14(+2,03%)
Nikkei 225
37.934,76
+306,28(+0,81%)
Petrolio
83,66
+0,09(+0,11%)
Bitcoin EUR
58.961,64
-1.215,42(-2,02%)

RAYTHEON TECHNOLOGIES CORP (^RTX)

Vienna - Vienna Prezzo differito. Valuta in EUR.

Aggiungi a watchlist

94,35

-1.177,46

(-92,58%)

Alla chiusura: 05:32PM CEST

Capitalizzazione	N/D
Beta (5 anni mensile)	N/D
Rapporto PE (ttm)	N/D
EPS (ttm)	N/D
Prossima data utili	N/D
Rendimento e dividendo (futuro)	N/D (N/D)
Data ex dividendo	N/D
Stima target 1A	N/D

Tutte

GlobeNewswire
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed